Login to Your Account

Ilypsa, Take Two

Amgen Spinout Relypsa Starts Business With $33M Series A

By Jennifer Boggs

Wednesday, October 31, 2007
If the story of newly established Relypsa Inc., a company created to develop nonabsorbed polymeric drugs for renal and cardiovascular diseases, sounds more than a little familiar, that's probably because it is. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription